SNYR Fundamental Analysis - SYNERGY CHC CORP

Fundamental Rating

SNYR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Personal Care Products industry. SNYR has only an average score on both its financial health and profitability. SNYR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.

Quickly go to:

1. Profitability

1.1 Basic Checks

SNYR had positive earnings in the past year.

The reported net income has been mixed in the past 5 years: SNYR reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: SNYR reported negative operating cash flow in multiple years.

1.2 Ratios

With an excellent Return On Assets value of 16.42%, SNYR belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.

SNYR has a better Return On Invested Capital (32.60%) than 96.97% of its industry peers.

		Industry Rank	Sector Rank
ROA	16.42%
ROE	N/A
ROIC	32.6%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SNYR's Profit Margin of 9.61% is amongst the best of the industry. SNYR outperforms 84.85% of its industry peers.

Looking at the Operating Margin, with a value of 17.75%, SNYR belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.

In the last couple of years the Operating Margin of SNYR has grown nicely.

SNYR has a better Gross Margin (70.31%) than 60.61% of its industry peers.

SNYR's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	17.75%
PM (TTM)	9.61%
GM	70.31%

OM growth 3YN/A

OM growth 5Y22.69%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-0.29%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNYR is creating value.

The number of shares outstanding for SNYR has been increased compared to 1 year ago.

Compared to 5 years ago, SNYR has more shares outstanding

The debt/assets ratio for SNYR has been reduced compared to a year ago.

2.2 Solvency

SNYR has an Altman-Z score of 1.03. This is a bad value and indicates that SNYR is not financially healthy and even has some risk of bankruptcy.

SNYR has a worse Altman-Z score (1.03) than 75.76% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	1.03

ROIC/WACC3.3

WACC9.88%

2.3 Liquidity

A Current Ratio of 2.74 indicates that SNYR has no problem at all paying its short term obligations.

SNYR's Current ratio of 2.74 is fine compared to the rest of the industry. SNYR outperforms 69.70% of its industry peers.

SNYR has a Quick Ratio of 2.41. This indicates that SNYR is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of SNYR (2.41) is better than 75.76% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.74
Quick Ratio	2.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SNYR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.60%.

Looking at the last year, SNYR shows a very negative growth in Revenue. The Revenue has decreased by -18.57% in the last year.

SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.

EPS 1Y (TTM)-67.6%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-18.57%

Revenue growth 3YN/A

Revenue growth 5Y3.48%

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SNYR will show a very strong growth in Earnings Per Share. The EPS will grow by 41.50% on average per year.

The Revenue is expected to grow by 20.94% on average over the next years. This is a very strong growth

EPS Next Y13.89%

EPS Next 2Y11.8%

EPS Next 3Y41.5%

EPS Next 5YN/A

Revenue Next Year23.04%

Revenue Next 2Y25.98%

Revenue Next 3Y20.94%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.74, which indicates a rather cheap valuation of SNYR.

SNYR's Price/Earnings ratio is rather cheap when compared to the industry. SNYR is cheaper than 96.97% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 26.83, SNYR is valued rather cheaply.

The Price/Forward Earnings ratio is 5.58, which indicates a rather cheap valuation of SNYR.

96.97% of the companies in the same industry are more expensive than SNYR, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 22.82. SNYR is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	6.74
Fwd PE	5.58

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNYR indicates a somewhat cheap valuation: SNYR is cheaper than 69.70% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	8.53

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as SNYR's earnings are expected to grow with 41.50% in the coming years.

PEG (NY)0.49

PEG (5Y)N/A

EPS Next 2Y11.8%

EPS Next 3Y41.5%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SNYR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SYNERGY CHC CORP

NASDAQ:SNYR (10/23/2025, 8:00:02 PM)

2.56

-0.13 (-4.83%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)08-14 2025-08-14/bmo

Earnings (Next)11-13 2025-11-13

Inst Owners3.82%

Inst Owner ChangeN/A

Ins Owners7%

Ins Owner Change0.02%

Market Cap28.65M

Revenue(TTM)33.70M

Net Income(TTM)3.24M

Analysts82.86

Price Target10.2 (298.44%)

Short Float %3.13%

Short Ratio1.36

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)74.19%

Min EPS beat(2)40.06%

Max EPS beat(2)108.33%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-18.71%

Min Revenue beat(2)-26.16%

Max Revenue beat(2)-11.25%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-90.91%

EPS NY rev (1m)0%

EPS NY rev (3m)-14.58%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-9.92%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-8.22%

Valuation

		Industry Rank	Sector Rank
PE	6.74
Fwd PE	5.58
P/S	0.85
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	8.53

EPS(TTM)0.38

EY14.84%

EPS(NY)0.46

Fwd EY17.93%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS3.01

BVpS-1.11

TBVpS-1.13

PEG (NY)0.49

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	16.42%
ROE	N/A
ROCE	47.47%
ROIC	32.6%
ROICexc	36.28%
ROICexgc	36.9%
OM	17.75%
PM (TTM)	9.61%
GM	70.31%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5Y22.69%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-0.29%

F-ScoreN/A

Asset Turnover1.71

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	4.4
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.74
Quick Ratio	2.41
Altman-Z	1.03

F-ScoreN/A

WACC9.88%

ROIC/WACC3.3

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-67.6%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y13.89%

EPS Next 2Y11.8%

EPS Next 3Y41.5%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.57%

Revenue growth 3YN/A

Revenue growth 5Y3.48%

Sales Q2Q%N/A

Revenue Next Year23.04%

Revenue Next 2Y25.98%

Revenue Next 3Y20.94%

Revenue Next 5YN/A

EBIT growth 1Y-46.32%

EBIT growth 3YN/A

EBIT growth 5Y26.96%

EBIT Next Year68.78%

EBIT Next 3Y35.04%

EBIT Next 5YN/A

FCF growth 1Y-1239.06%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1239.06%

OCF growth 3YN/A

OCF growth 5YN/A

SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens